These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 8069298
21. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Ueki K, Wen-Bin C, Narita Y, Asai A, Kirino T. Cancer Res; 1999 Dec 01; 59(23):5995-8. PubMed ID: 10606247 [Abstract] [Full Text] [Related]
22. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, Bigozzi U. Hum Genet; 1995 Mar 01; 95(3):347-51. PubMed ID: 7868131 [Abstract] [Full Text] [Related]
23. Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Arakawa H, Hayashi N, Nagase H, Ogawa M, Nakamura Y. Hum Mol Genet; 1994 Apr 01; 3(4):565-8. PubMed ID: 8069299 [Abstract] [Full Text] [Related]
29. NF2 mutations in secretory and other rare variants of meningiomas. Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A. Brain Pathol; 2006 Jan 01; 16(1):15-9. PubMed ID: 16612978 [Abstract] [Full Text] [Related]
30. Reduced expression of schwannomin/merlin in human sporadic meningiomas. Lee JH, Sundaram V, Stein DJ, Kinney SE, Stacey DW, Golubić M. Neurosurgery; 1997 Mar 01; 40(3):578-87. PubMed ID: 9055299 [Abstract] [Full Text] [Related]
32. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain. Koga H, Araki N, Takeshima H, Nishi T, Hirota T, Kimura Y, Nakao M, Saya H. Oncogene; 1998 Aug 20; 17(7):801-10. PubMed ID: 9779996 [Abstract] [Full Text] [Related]
33. Loss of merlin-p85 protein complex in NF2-related tumors. Takeshima H, Nishi T, Yamamoto K, Kino T, Nakamura H, Saya H, Kochi M, Kuratsu JI, Ushio Y. Int J Oncol; 1998 May 20; 12(5):1073-8. PubMed ID: 9538131 [Abstract] [Full Text] [Related]
34. The mouse homologue of the neurofibromatosis type 2 gene is highly conserved. Claudio JO, Marineau C, Rouleau GA. Hum Mol Genet; 1994 Jan 20; 3(1):185-90. PubMed ID: 8162023 [Abstract] [Full Text] [Related]
35. Familial meningioma is not allelic to neurofibromatosis 2. Pulst SM, Rouleau GA, Marineau C, Fain P, Sieb JP. Neurology; 1993 Oct 20; 43(10):2096-8. PubMed ID: 8413972 [Abstract] [Full Text] [Related]
38. The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas. Kimura Y, Koga H, Araki N, Mugita N, Fujita N, Takeshima H, Nishi T, Yamashima T, Saido TC, Yamasaki T, Moritake K, Saya H, Nakao M. Nat Med; 1998 Aug 20; 4(8):915-22. PubMed ID: 9701243 [Abstract] [Full Text] [Related]
39. Multiple transcription initiation sites, alternative splicing, and differential polyadenylation contribute to the complexity of human neurofibromatosis 2 transcripts. Chang LS, Akhmametyeva EM, Wu Y, Zhu L, Welling DB. Genomics; 2002 Jan 20; 79(1):63-76. PubMed ID: 11827459 [Abstract] [Full Text] [Related]
40. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Mérel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X. Genes Chromosomes Cancer; 1995 Jul 20; 13(3):211-6. PubMed ID: 7669741 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]